Drug
Ferric carboxymaltose clinical trials
Also written Injectafer and VIT-45.
Keep track of what changes. Save the ferric carboxymaltose studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Development codes
Studies by the year they started
159 studies that test it; most in 2017 (18)
| Year | Studies |
|---|---|
| 2005 | 5 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 8 |
| 2010 | 7 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 8 |
| 2014 | 9 |
| 2015 | 9 |
| 2016 | 6 |
| 2017 | 18 |
| 2018 | 5 |
| 2019 | 10 |
| 2020 | 8 |
| 2021 | 9 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 8 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
- Anemia
- 20
Who runs them
Industry 46 · Other 113
American Regent, Inc. (28) · Vifor Pharma (12) · University of Zurich (5) · Sichuan Huiyu Pharmaceutical Co., Ltd (3) · University of Oxford (3) · Konkuk University Medical Center (3) · Vifor (International) Inc. (2) · National Cancer Center, Korea (2)
Often tested with
Tested in the same studies.
Ferrous sulfate (5) · Iron sucrose (4) · Folic Acid (3) · Iron isomaltoside 1000 (3) · Ferrous fumarate (3) · Erythropoietin (2) · Sodium Chloride (2) · Ferroglycine sulfate (1)
Studies
Open first, then newest update. How each study uses ferric carboxymaltose is read from its arms, and is right about nine times in ten.
Testing it · 159
- Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants Under Fasting ConditionsRecruitingPhase 1Sichuan Huiyu Pharmaceutical Co., LtdNCT07606105Written as Ferric Carboxymaltose Injection
- Intravenous Iron in the Management of Drug-resistant Restless Legs syndromeINot yet recruitingPhase 2University Hospital, MontpellierNCT07822607Written as Ferric Carboxymaltose Injection [Ferinject]
- Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency AnemiaRecruitingPhase 4Western Galilee Hospital-NahariyaNCT06061393Written as Ferinject
- Ferric Carboxymaltose Versus Iron Sucrose for Iron Deficiency Anemia After Radical Gastrectomy for Gastric CancerNot yet recruitingPhase 4Zhaojian Niu,MDNCT07772453Written as Ferric Carboxymaltose (FCM)
- Comparing Two Intravenous Iron Treatments for Anemia in Kurdish Pregnant WomenNot yet recruitingNot applicableHawler Medical UniversityNCT07721519Written as Intravenous Ferric Carboxymaltose (FCM)
- The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)RecruitingPhase 4Tomsk National Research Medical Center of the Russian Academy of SciencesNCT05793996Written as Ferinject
- Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)RecruitingPhase 3Asan Medical CenterNCT05226169Written as Ferinject
- Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary SyndromeRecruitingPhase 4Fundación para la Investigación del Hospital Clínico de ValenciaNCT07476859Written as Ferric Carboxymaltose Injection [Ferinject]
- The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency DepartmentNot yet recruitingPhase 4Children's Hospital of Orange CountyNCT07414199Written as Ferric Carboxymaltose (FCM)
- The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary HypertensionRecruitingPhase 4Ziekenhuis Oost-LimburgNCT07359599Written as Ferric Carboxymaltose (FCM)
- Iron Infusion in Patients Undergoing Transcatheter Aortic Valve ImplantationRecruitingPhase 4Erasmus Medical CenterNCT07370688Written as Intravenous ferric carboxymaltose
- IntraVenous Iron in Kids With Iron Deficiency and Scoliosis StudyRecruitingPhase 2/3Columbia UniversityNCT07217873Written as Ferric carboxymaltose IV
- Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTionRecruitingPhase 4Wroclaw Medical UniversityNCT05759078Written as Ferinject
- The Effectiveness of Preoperative Iron Therapy in Improving Anemia After Multi-level Lumbar Fusion in the ElderlyRecruitingNot applicableXuanwu Hospital, BeijingNCT07057973Written as Ferric carboxymaltose
- Intravenous Iron Effects on Performance at High AltitudeRecruitingPhase 4United States Army Research Institute of Environmental MedicineNCT06686693Written as Injectafer
- Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trialRecruitingPhase 3Jon UnossonNCT05744219Written as Ferric carboxymaltose
- IV Iron-induced Hypophosphatemia After RYGBRecruitingPhase 4Lucie FavreNCT06350955Written as Iron Carboxymaltose
- IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron DeficiencyNot yet recruitingPhase 3Hospital de Clinicas de Porto AlegreNCT06434025Written as Iron Carboxymaltose
- Preoperative i.v. Iron Substitution in Patients With Colon CancerRecruitingNot applicableHelsinki University Central HospitalNCT04653181Written as Ferric carboxymaltose
- Impact of Intravenous Iron on Musculoskeletal Function in Older AdultsNot yet recruitingPhase 4Liverpool Hope UniversityNCT05708170Written as Ferinject
See all 159 studies that test ferric carboxymaltose →
Given in every arm · 2 — ferric carboxymaltose is usual care beside what is tested
- Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)TerminatedPhase 4Assistance Publique - Hôpitaux de ParisNCT05114278Written as Ferinject
- A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)CompletedPhase 3German Breast GroupNCT02125344Written as Ferric carboxymaltose
As the comparator · 10 — what is tested is compared with ferric carboxymaltose
- A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency AnemiaNot yet recruitingPhase 3AFT Pharmaceuticals, Ltd.NCT07687784Written as Ferric Carboxymaltose Injection [Ferinject]
- Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron DeficiencyNot yet recruitingPhase 4University of PadovaNCT05702970Written as Ferric Carboxymaltose 50 MG/ML
- Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron DeficiencyCompletedPhase 3Prof. Dr. Frank BehrensNCT03817957Written as Ferric carboxymaltose
- Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in PatientsWithdrawnPhase 3Dr. Frank BehrensNCT04087993Written as Ferric carboxymaltose
- A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)CompletedPhase 3AMAG Pharmaceuticals, Inc.NCT02694978Written as FCM
- A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel DiseaseCompletedPhase 4Pharmacosmos A/SNCT03466983Written as Ferric Carboxymaltose
- A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or MonoferCompletedPhase 4Universität des SaarlandesNCT02905539Written as Ferric Carboxymaltose
- Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic TrialStatus unknownPhase 3Fondazione IRCCS Policlinico San Matteo di PaviaNCT04587141Written as Ferric carboxymaltose
- Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency AnaemiaCompletedPhase 3Pharmacosmos A/SNCT03237065Written as Ferric carboxymaltose
- Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency AnaemiaCompletedPhase 3Pharmacosmos A/SNCT03238911Written as Ferric carboxymaltose
Codes
What other systems call ferric carboxymaltose · ClinicalTrials.gg INT005146
- MeSH (NLM) C522335ferric carboxymaltoseConfirmed NLM, Wikidata
- UNII (FDA) 6897GXD6OEFERRIC CARBOXYMALTOSEConfirmed FDA, NLM, Wikidata
- RxNorm 1433693Confirmed FDA, Wikidata
- Wikidata Q20817270ferric carboxymaltoseConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166915Ferric CarboxymaltoseOne source FDA
- DrugBank DB08917One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C522335 | ferric carboxymaltose | Confirmed NLM, Wikidata |
| UNII (FDA) | 6897GXD6OE | FERRIC CARBOXYMALTOSE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1433693 | — | Confirmed FDA, Wikidata |
| Wikidata | Q20817270 | ferric carboxymaltose | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166915 | Ferric Carboxymaltose | One source FDA |
| DrugBank | DB08917 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.